MYC and lung carcinoma: Its expression level was increased in lung cancer, prostate cancer, and cervical cancer, [43, 44] elevated WNT1 expression was also detected in over 1/3 of NSCLC cases, and was positively correlated with the expression levels of β-catenin, Cyclin D1, and c-Myc.